Mouse model for pre-clinical study of human cancer immunotherapy

Zhiya Ya, Yared Hailemichael, Willem Overwijk, Nicholas P. Restifo

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

This unit describes protocols for developing tumors in mice, including subcutaneous growth, pulmonary metastases of B16 melanoma, and spontaneous melanoma in B-Raf V600E/PTEN deletion transgenic mouse models. Two immunization methods to prevent B16 tumor growth are described usingB16.GMCSF and recombinant vaccinia virus. A therapeutic approach is also included that uses adoptive transfer of tumor antigen-specific T cells. Methods including CTL induction, isolation, testing, and genetic modification of mouse T cells for adoptive transfer by using retrovirus-expressing genes of interest are provided. Additional sections, including growing B16 melanoma, enumerating pulmonary metastases, tumor imaging technique, and use of recombinant viruses for vaccination, are discussed together with safety concerns.

Original languageEnglish (US)
Pages (from-to)20.1.1-20.1.43
JournalCurrent Protocols in Immunology
Volume2015
DOIs
StatePublished - 2015

Keywords

  • B16 melanoma
  • Translational cancer immunotherapy
  • Tumor imaging
  • Use of recombinant viruses for vaccination

ASJC Scopus subject areas

  • Immunology

MD Anderson CCSG core facilities

  • Research Animal Support Facility

Fingerprint

Dive into the research topics of 'Mouse model for pre-clinical study of human cancer immunotherapy'. Together they form a unique fingerprint.

Cite this